" class="no-js "lang="en-US"> James C. D'Arecca - Medtech Alert
Saturday, December 14, 2024
James D'Arecca

James C. D’Arecca

About James C. D’Arecca

D’Arecca has nearly 30 years of experience in finance leadership and strategy. Since June 2020, he has served as Chief Financial Officer of TherapeuticsMD, a women’s healthcare company. Previously, D’Arecca was Senior Vice President and Chief Accounting Officer at Allergan plc for nearly seven years until its merger with AbbVie, Inc. in May 2020, and earlier in his career he held finance and business development positions at Bausch + Lomb, Merck & Co., Inc., and Schering-Plough. D’Arecca began his career with PricewaterhouseCoopers, where he had an industry focus on pharmaceuticals, medical devices, and consumer products.

D’Arecca received a Bachelor of Science in Accounting from Rutgers University and a Master of Business Administration from Columbia University.

Related Story

Haemonetics Appoints James D'Arecca Chief Financial Officer

March 22 2022

Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive […]